Humoral immunodeficiency in chronic lymphocytic leukemia: Role of CD95/CD95L in tumoral damage and escape

Leukemia and Lymphoma

Volumn 43, Issue 4, 2002, Pages 881-884

  Sampalo, Almudena ^a   Brieva, José A ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

CD95 CD95L; Chronic lymphocytic leukemia; CLL; Humoral immunodeficiency; Tumoral escape

Indexed keywords

FAS ANTIGEN; FAS LIGAND; IMMUNOGLOBULIN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL DAMAGE; CELL MATURATION; CHRONIC LYMPHATIC LEUKEMIA; DISEASE ASSOCIATION; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; HUMORAL IMMUNE DEFICIENCY; HYPOGAMMAGLOBULINEMIA; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; INFECTION; INHIBITION KINETICS; PLASMA CELL; PRIORITY JOURNAL; PROTEIN INTERACTION; T LYMPHOCYTE; TUMOR CELL; TUMOR ESCAPE;

AGAMMAGLOBULINEMIA; ANTIGENS, CD95; FAS LIGAND PROTEIN; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MEMBRANE GLYCOPROTEINS; T-LYMPHOCYTES; TUMOR ESCAPE;

EID: 0036240490     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190290017033     Document Type: Article

References (45)

1. "Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: Role of CD95-CD95L interaction"
2. "B-cell chronic lymphocytic leukemia: Present status and future directions"
3. "Advances in the biology and treatment of B cell chronic lymphatic leukaemia"
4. "CD5 B cells, a fetal B cell lineage"
5. "CD5 expression in human B cell populations"
6. "Chronic lymphocytic leukaemia"
7. "Hypogammaglobulinemia and chronic lymphocytic leukaemia"
8. "Immunological deficiency disorders associated with chronic lymphocytic leukaemia and multiple myeloma"
9. "Mechanism of infections in chronic lymphatic leukaemia"
10. "Clinical correlations with immunoglobulin levels in chronic lymphatic leukaemia"
11. "Abnormal T-cell subpopulation function in CLL, Excessive suppressor and deficient helper (T) activity with respect to B-cell proliferation"
12. "T cell helper defect in patients with chronic lymphocytic leukaemia"
13. "Impaired synthesis of immunoglobulin in patients with chronic lymphocytic leukemia"
14. "Evidence that large granular lymphocytes from B-CLL patients with hypogammaglobulinemia down-regulate B-cell immunoglobulin synthesis"
15. "National Cancer Institute sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment"
16. "A model for human B-chronic lymphocytic leukemia in human/mouse radiation chimera: Evidence for tumor-mediated suppression of antibody production in low stage disease"
17. "Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand tumor cells in B chronic lymphocytic leukemia"
18. "The Fas death receptor"
19. "Dysregulation of CD30+ T cells by leukemia impairs isotype switching in normal B cells"
20. "Acquired CD40-ligand deficiency in chronic lymphatic leukemia"
21. "Antibody class switching"
22. "Heterogeneity of serum IgG subclass deficiencies in B chronic lymphocytic leukemia"
23. "Immunoglobulin synthesis by human lymphoid tissues: Normal bone marrow as a major site of IgG production"
24. "The bone marrow: The major source of immunoglobulins, but still neglected site of antibody formation"
25. "Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily in normal and neoplastic cells"
26. "Die and let live: Eliminating dangerous lymphocytes"
27. "Regulatory role of CD95 ligation on human B cells induced in vivo capable of spontaneous and high rate Ig secretion"
28. "Coming to terms with death: Apoptosis in cancer and immune development"
29. "Fas and fas-ligand: lpr and gld mutations"
30. "Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome"
31. "Immune privilege or inflammation? Insights into the fas ligand enigma"
32. "Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins"
33. "Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin"
34. "Significance of Fas antigen mediated apoptosis in human fulminant hepatic failure"
35. "Fas-L up-regulation by highly malignant myeloma plasma cells: Role in the pathogenesis of anemia and disease progression"
36. "Discrimination of human leukaemia subtypes by flow cytometer analysis of cellular DNA and RNA"
37. "Apoptosis and cancer: Strategies for integrating programmed cell death"
38. "Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: A potential mechanism of tumor-induced suppression of immune surveillance"
39. "The fas counterattack: Fas-mediated T cell killing by colon cancer expressing Fas ligand"
40. "Melanoma cell expression of Fas (Apo-1/CD95) ligand: Implications for tumor immune escape"
41. "Fas-ligand expression by astrocytoma in vivo: Maintaining immune privilege in the brain?"
42. "The status of Fas and Fas-ligand expression can predict recurrence of hepatocellular carcinoma"
43. "FasL:Fas ratio, a prognostic factor in breast carcinoma"
44. "Expression of Fas ligand and other apoptosis-related genes and their prognostic significance in epithelial ovarian neoplasms"
45. "FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas"